Picture of Cytokinetics logo

CYTK Cytokinetics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Annual cashflow statement for Cytokinetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-122-127-215-389-526
Depreciation
Non-Cash Items33.446.562.110896.9
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3.8987.98.46-24.73.09
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-90.98.94-143-300-414
Capital Expenditures-2.62-11.1-48.9-11.3-1.42
Purchase of Fixed Assets
Other Investing Cash Flow Items-72.1-185-98.9-251241
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-74.7-197-148-262239
Financing Cash Flow Items-13.42.15014.4-10.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities160234320516221
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.8246.629.7-45.546.2